A Phase 2, Randomized, Placebo-Controlled, Multiple Ascending-Dose Study of ACE-031, a Soluble Activin Receptor Type IIB, in Boys with Duchenne Muscular Dystrophy (DMD) (P04.088) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Campbell, C
  • Escolar, D
  • Mah, J
  • Tarnopolsky, Mark
  • Selby, K
  • McMillan, H
  • Yang, Y
  • Wilson, D
  • Barger, R
  • Sherman, M
  • Attie, K

publication date

  • April 25, 2012